Proteasome inhibitor bortezomib-induced apoptosis in natural killer (NK)-cell leukemia and lymphoma: an in vitro and in vivo preclinical evaluation.
Shen
Lijun
L
Au
Wing-Yan
WY
Guo
Tianhuan
T
Wong
Kai-Yau
KY
Wong
Michelle L
ML
Tsuchiyama
Junjiro
J
Yuen
Po-Wing
PW
Kwong
Yok-Lam
YL
Liang
Raymond H
RH
Srivastava
Gopesh
G
D017209:Apoptosis / Q000187:drug effects; D001897:Boronic Acids / Q000627:therapeutic use*; D000069286:Bortezomib; D045744:Cell Line, Tumor; D004354:Drug Screening Assays, Antitumor; D006801:Humans; D007694:Killer Cells, Natural / Q000187:drug effects / Q000473:pathology*; D015458:Leukemia, T-Cell / Q000188:drug therapy* / Q000473:pathology; D016399:Lymphoma, T-Cell / Q000188:drug therapy* / Q000473:pathology; D011480:Protease Inhibitors / Q000627:therapeutic use; D011719:Pyrazines / Q000627:therapeutic use*; D014407:Tumor Cells, Cultured
D001897:Boronic Acids; D011480:Protease Inhibitors; D011719:Pyrazines; D000069286:Bortezomib